The Lymphoma Academic Research Organisation

This study tests a treatment called axi-cel (a CAR T-cell therapy) for people with aggressive B-cell lymphoma that has come back or not responded to treatment, and who cannot have a stem cell transplant. The goal is to see if this therapy can make the cancer disappear completely.…

This study tests an experimental drug called valemetostat tosylate in 141 people with B-cell lymphoma that has returned or not responded to prior therapy. The drug is a pill taken by mouth that aims to shrink tumors. Researchers are checking how well it works and how safe it is a…

This study tests whether adding venetoclax to a standard treatment (ibrutinib plus a CD20 antibody) works better for people newly diagnosed with mantle cell lymphoma, a rare blood cancer. About 194 adults aged 18 to 79 will receive either the standard combo or the three-drug comb…